Aprepitant/Fosaprepitant Dimeglumine and DAUNOrubicin and Cytarabine
Determining the interaction of Aprepitant/Fosaprepitant Dimeglumine and DAUNOrubicin and Cytarabine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: cytarabine liposomal / daunorubicin liposomal
Brand name: Vyxeos
Synonyms: Cytarabine and daunorubicin (liposomal), Daunorubicin and Cytarabine (Liposomal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant/Fosaprepitant Dimeglumine-Daunorubicin and Cytarabine (Liposomal)
- Aprepitant/Fosaprepitant Dimeglumine-Daunorubicin and cytarabine liposome Intravenous
- Aprepitant/Fosaprepitant Dimeglumine-Daunorubicin citrate
- Aprepitant/Fosaprepitant Dimeglumine-Daunorubicin citrate liposome Intravenous
- Aprepitant/Fosaprepitant Dimeglumine-Daunorubicin hydrochloride
- Aprepitant/Fosaprepitant Dimeglumine-Daunorubicin Intravenous
- DAUNOrubicin and Cytarabine-Apresazide
- DAUNOrubicin and Cytarabine-Apresoline
- DAUNOrubicin and Cytarabine-Apresoline Injection
- DAUNOrubicin and Cytarabine-Apri
- DAUNOrubicin and Cytarabine-Apriso
- DAUNOrubicin and Cytarabine-Aprizio Pak